Because of great species variation in the effectsThe pharmacology of neuromuscular blocking agents has been studied extensively in laboratory animals and has been the subject of numerous publications. Because of the large quantitative and qualitative species variation in the neuromuscular and other effects of relaxants,125,303,406 the results of animal experiments are frequently not applicable to man and it has been emphasized repeatedly that their pharmacologic actions should be studied in human subjects. 124 ,304.376,382 Considerable information is available on the human pharmacology of neuromuscular blocking agents in monographs 124 ,331 and symposia,321,368 but so far no attempt has been made to review in a single publication the literature on the human pharmacology of muscle relaxants.In the foUowing pages an attempt will be made to correlate the pharmacologic effects of neuromuscular blocking agents with their safe and efficient clinical administration. This survey will deal primarily with the quaternary ammonium type myoneural blocking agents and, of these, only those compounds will be discussed which have been widely used clinically or the study of which serves to emphasize basic principles of the human pharmacology of relaxants.The list of neuromuscular blocking agents to be reviewed is presented in Table 1.Limitations inherent in the pharmacologic study of any drug in human subjects have also influenced the investigation of neuromuscular blocking agents. Thus, little or no information is available on their acute and chronic toxicity in man and, with few exceptions, all observations were made in the intact organism, instead of on isolated nerve-muscle preparations. On the other hand, in eonjunetion with their clinieal use, there has been ample opportunity to observe the influence of various pathologie conditions and of other drugs on the pharmacologic action of relaxant drugs. Further-
345